Drug Trial Radar · NCT00000922
A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
Last checked: Nov 19, 2026Latest source record: Apr 17, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,710
Actual
Start
Not stated
Primary completion
Jan 2003
Study completion Jun 2006
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether it is better to start an anti-HIV regimen containing a protease inhibitor (PI), a non-nucleoside reverse transcriptase inhibitor (NNRTI), or a PI in combination with an NNRTI. This study will also examine which treatment regimen is best as a first treatment for HIV infection.
Conditions
- HIV Infections
Interventions
Indinavir sulfateDrug
Abacavir sulfateDrug
Nelfinavir mesylateDrug
EfavirenzDrug
NevirapineDrug
LamivudineDrug
StavudineDrug
DidanosineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in CD4 count from baseline to the average of all readings obtained at the regular follow-up visits beginning at Month 32
- time to disease progression, death, or CD4 count less than 200 cells/mm3 at the 4 Month visit for those patients with a baseline CD4 cell count of more than or equal to 200 cells/mm3
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Community Consortium / UCSF
San Francisco, California
Denver CPCRA / Denver Public Hlth
Denver, Colorado
Yale Univ School of Medicine / AIDS Program
New Haven, Connecticut
Washington Reg AIDS Prog / Dept of Infect Dis
Washington D.C., District of Columbia
AIDS Research Consortium of Atlanta
Atlanta, Georgia
AIDS Research Alliance - Chicago
Chicago, Illinois
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med
New Orleans, Louisiana
Wayne State Univ - WSU/DMC / Univ Hlth Ctr
Detroit, Michigan
Henry Ford Hosp
Detroit, Michigan
Southern New Jersey AIDS Cln Trials / Dept of Med
Camden, New Jersey
North Jersey Community Research Initiative
Newark, New Jersey
Partners in Research / New Mexico
Albuquerque, New Mexico
Harlem AIDS Treatment Grp / Harlem Hosp Ctr
New York, New York
The Research and Education Group
Portland, Oregon
Philadelphia FIGHT
Philadelphia, Pennsylvania
Univ TX Health Science Ctr
Houston, Texas
Richmond AIDS Consortium / Div of Infect Diseases
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.